1. Zhou, Qing, Liu, Ying, Zhou, Jieyu, Zhang, Wenling. 2024. Prognostic value and immunological role of MMRN1: a rising star in cancer. In Nucleosides, nucleotides & nucleic acids, 44, 148-169. doi:10.1080/15257770.2024.2335680. https://pubmed.ncbi.nlm.nih.gov/38715238/
2. Saini, Abhinav, Chandra, Kumari Binita, Kumar, Vikrant, Kumar, Sunesh, Yadav, Savita. 2020. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer. In Molecular biology reports, 47, 9459-9468. doi:10.1007/s11033-020-06027-9. https://pubmed.ncbi.nlm.nih.gov/33263168/
3. Booms, Alix, Pierce, Steven E, van der Schans, Edwin J C, Coetzee, Gerhard A. 2024. Parkinson's disease risk enhancers in microglia. In iScience, 27, 108921. doi:10.1016/j.isci.2024.108921. https://pubmed.ncbi.nlm.nih.gov/38323005/
4. Laszlo, George S, Alonzo, Todd A, Gudgeon, Chelsea J, Meshinchi, Soheil, Walter, Roland B. 2015. Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. In Clinical cancer research : an official journal of the American Association for Cancer Research, 21, 3187-95. doi:10.1158/1078-0432.CCR-14-2684. https://pubmed.ncbi.nlm.nih.gov/25825478/
5. Wang, Quan, Shen, Yilin, Ye, Bin, Ma, Yan, Xiang, Mingliang. 2018. Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue. In Oncology reports, 40, 3359-3369. doi:10.3892/or.2018.6717. https://pubmed.ncbi.nlm.nih.gov/30272326/
智鼠故事 
